{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:20:19Z","timestamp":1787678419270,"version":"build-2784847793"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015269","name":"Innov\u00e1ci\u00f3s \u00e9s Technol\u00f3giai Miniszt\u00e9rium","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003827","name":"Nemzeti Kutatasi Fejlesztesi es Innovacios Hivatal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003825","name":"Hungarian Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003825","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijcard.2026.134686","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T14:53:25Z","timestamp":1784645605000},"page":"134686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Inflammasome pathway component expressions in myocardial samples of advanced heart failure patients treated with novel heart failure pharmacotherapies"],"prefix":"10.1016","volume":"462","author":[{"given":"D\u00e1vid","family":"Nagy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zs\u00f3fia","family":"On\u00f3di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00edmea","family":"B\u00e1lint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Horv\u00e1th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Ol\u00e1h","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex Ali","family":"Sayour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1lint Andr\u00e1s","family":"Barta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Ferdinandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Radovits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9la","family":"Merkely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mih\u00e1ly","family":"Ruppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ijcard.2026.134686_bb0005","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.ijcard.2026.134686_bb0010","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ijcard.2026.134686_bb0015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10557-017-6725-2","article-title":"SGLT-2 inhibition with Dapagliflozin reduces the activation of the Nlrp3\/ASC Inflammasome and attenuates the development of diabetic cardiomyopathy in mice with type 2 diabetes. Further augmentation of the effects with Saxagliptin, a DPP4 inhibitor","volume":"31","author":"Ye","year":"2017","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"5","key":"10.1016\/j.ijcard.2026.134686_bb0020","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10557-020-06995-x","article-title":"Protection of Sacubitril\/valsartan against pathological cardiac remodeling by inhibiting the NLRP3 Inflammasome after relief of pressure overload in mice","volume":"34","author":"Li","year":"2020","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"7","key":"10.1016\/j.ijcard.2026.134686_bb0025","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1111\/bph.70250","article-title":"The anti-fibrotic effects of novel heart failure pharmacotherapies in advanced heart failure patients","volume":"183","author":"Nagy","year":"2026","journal-title":"Br. J. Pharmacol."},{"issue":"13","key":"10.1016\/j.ijcard.2026.134686_bb0030","first-page":"2639","article-title":"AIM2-driven inflammasome activation in heart failure","volume":"117","author":"Onodi","year":"2021","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.ijcard.2026.134686_bb0035","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1002\/ehf2.15362","article-title":"Multiorgan characterization of inflammasome component expression in a rat model of advanced heart failure","volume":"12","author":"Nagy","year":"2025","journal-title":"ESC Heart Fail."},{"issue":"1","key":"10.1016\/j.ijcard.2026.134686_bb0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/FJC.0000000000000931","article-title":"Phase 1B, randomized, double-blinded, dose escalation, single-center, repeat dose safety and pharmacodynamics study of the Oral NLRP3 inhibitor Dapansutrile in subjects with NYHA II-III systolic heart failure","volume":"77","author":"Wohlford","year":"2020","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijcard.2026.134686_bb0045","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s00011-025-02078-5","article-title":"The role of absent in melanoma 2 (AIM2) in cardiovascular diseases","volume":"74","author":"Pan","year":"2025","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ijcard.2026.134686_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1178662","article-title":"Gasdermin D-mediated pyroptosis: mechanisms, diseases, and inhibitors","volume":"14","author":"Dai","year":"2023","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.ijcard.2026.134686_bb0055","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s41419-021-04240-3","article-title":"A long way to go: caspase inhibitors in clinical use","volume":"12","author":"Dhani","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.ijcard.2026.134686_bb0060","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-kappaB in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.ijcard.2026.134686_bb0065","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/rheumatology\/keu318","article-title":"Sex-dependent differential activation of NLRP3 and AIM2 inflammasomes in SLE macrophages","volume":"54","author":"Yang","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ijcard.2026.134686_bb0070","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3389\/fneur.2019.00622","article-title":"A novel sex-dependent target for the treatment of postoperative pain: the NLRP3 Inflammasome","volume":"10","author":"Cowie","year":"2019","journal-title":"Front. Neurol."},{"issue":"11","key":"10.1016\/j.ijcard.2026.134686_bb0075","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1161\/CIRCRESAHA.116.306923","article-title":"Molecular and cellular mechanisms of cardiovascular disorders in diabetes","volume":"118","author":"Shah","year":"2016","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.ijcard.2026.134686_bb0080","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/sj.cdd.4402195","article-title":"Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration","volume":"14","author":"Petrilli","year":"2007","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.ijcard.2026.134686_bb0085","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2309579121","article-title":"Mechanistic basis for potassium efflux-driven activation of the human NLRP1 inflammasome","volume":"121","author":"Rozario","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752732600536X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752732600536X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:28:40Z","timestamp":1787675320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016752732600536X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":17,"alternative-id":["S016752732600536X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2026.134686","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammasome pathway component expressions in myocardial samples of advanced heart failure patients treated with novel heart failure pharmacotherapies","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2026.134686","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"134686"}}